FDA Logo links to FDA home page
U.S. Food and Drug Administration
HHS Logo links to Department of Health and Human Services website

FDA Home Page | Dockets Home Page | Dockets Contacts and Location | Operating Status
horizonal rule

Dockets

Note:  Many of the documents are in PDF format, and need the Adobe Acrobat Reader to review the files. Click on the Adobe icon below to download the free reader.

Dockets beginning in the year: 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 - 1976 | What's New

Year 2003

Docket Number

Title of Docket

2003P-0564
513(f) Reclassification Petition for In Vitro Diagnostics for Anti-Hepatitis A Virus IgM and Total Antibodies (New 8/24/07)
2003N-0561
Orthopedic Devices; Effective Date of the Proposed Requirement for Premarket Approval of the Hip Joint Metal/Polymer or Ceramic/Polymer Semi-Constrained Resurfacing Cemented Prosthesis (New 5/10/04)
2003Q-0559
Qualified Health Claim: Monounsaturated Fatty Acids and Reduced Risk of Coronary Heart Disease (Updated 3/10/04)
2003D-0554
Compliance Policy Guide Sec. 110.310 Prior Notice of Imported Food Under the Public Health Security and Bioterrorism Preparedness and Response Act of 2002 (Updated 6/8/05)
2003Q-0547
Health Claim Notification Based on Authoritative Statement: for Whole Grains and Coronary Heart Disease (New 12/10/03)
2003N-0496
(Formerly 03N-0496) Food Labeling: Health Claims; Dietary Guidance - selected documents (New 09/28/05)
2003D-0478

Guidance on Marketed Unapproved Drugs Compliance Policy Guide

2003N-0470
Preparation for ICH meetings and ICH 6 Conference in Osaka, Japan, November 9-15, 2003: Public Meeting (New 12/11/03)
2003P-0450
Denovo Reclassification Petition for West Nile Virus IgM Capture ELISA (New 8/23/07)
2003Q-0401
Qualified Health Claim (QHC) OMEGA-3 Fatty Acids and Coronary Heart Disease Health Claim (Updated 11/29/04)
2003D-0380
Draft Guidance for Industry: PAT - A Framework for Innovative Pharmaceutical Manufacturing and Quality Assurance; Availability
2003P-0366
Amend Approval for a Nonperscription Form of Priolosec (Omeprazole Magnesium) (New 12/9/04)
2003P-0365
Galderma Product, Solage Containing 2% Mequinol, and 0.01% Tretinoin, NDA 20-922 can be Formulated as a Topical Solution with the Substitution of Hydroquinone at 4% for the 2% Mequinol as an ANDA (New 12/29/04)
2003N-0338
Obesity (Updated 4/27/04)
2003N-0355
Medical Devices; Exception from General Requirements for Informed Consent (Updated 8/17/06)
2003P-0313
Canned Tuna Deviating From Identity Standard; Temporary Permit for Market Testing (New 8/23/07)
2003N-0312
Discussion of Animal Feed Safety System (AFSS): A Comprehensive Risk-Based Safety Program for the Manufacture and Distribution of Animal Feeds (Updated 7/1/05)
2003P-0296
Classification of Transscutaneous Air Conduction Hearing Aid (New 8/22/07)
2003N-0281
SARS Diagnostics: Scientific and Regulatory Challenges (Updated 7/29/03)
2003P-0274
In Re Tier 1 Initial Approval Program (Updated 10/5/04)
2003D-0263
Draft Guidance for Industry: Channels of Trade Policy for Commodities With Residues of Pesticide Chemicals, for Which Tolerances Have Been Revoked, Suspended, or Modified by the Environmental Protection Agency (New 6/6/05)
2003N-0207
Preparation for ICH Meetings in Brussels, Belgium, and ICH 6 Conference in Osaka, Japan: Public Meeting (New 7/29/03)
2003N-0205
Exocrine Pancreatic Insufficiency Drug Products (New 10/31/07)
2003D-0206
Draft Guidance for Industry on Exocrine Pancreatic Insufficiency Drug Products; Availability (New 9/21/05)
2003N-0205
Exocrine Pancreatic Insufficiency Drug Products (New 10/30/07)
2003N-0203
Innovative Systems for Delivery of Drugs and Biologics: Scientific, Clinical, and Regulatory Challenges; Public Workshop (Updated 7/30/03)
2003P-0176
Follow-On Approval of Therapeutic Protein Products (Updated 7/13/06)
2003N-0168
Current Status of Useful Written Prescription Drug Information for Consumers; Public Meeting - Transcript Only (New 11/25/03)
2003P-0090
Removing Serzone (NEFAZODONE) from the Market Bristal-Myers
2003P-0064
Withhold Approval of Generic Lovenox (enoxaparin sodium injection) (Updated 9/7/07)
2003D-0061
Guidance for Industry:  Comparability Protocols -- Chemistry,  Manufacturing, and Controls Information  (New  3/17/03)
2003D-0060
Guidance for Industry:  Part 11, Electronic Records; Electronic Signatures -- Scope and Application  (Updated  7/03/03)
2003N-0059
Pharmaceutical cGMPs for 21st Century: A Risk-Based Approach  (Updated  1/3/05)

Top

Page updated October 31, 2007 kk

Acrobat Reader Icon

Dockets Home Page | Dockets Contacts and Location | Operating Status| Item Code Definitions | Federal Register
FDA Home Page | Search FDA Site | A-Z Index | Contact FDA | Privacy | Accessibility

Division of Dockets Management